The Internet of Things (IoT) has emerged as a transformative technology in managing Alzheimer’s Disease (AD), offering novel solutions for early diagnosis, continuous patient monitoring, and assistive care. This review presents a comprehensive analysis of iot-enabled systems tailored to ad care, focusing on wearable biosensors, cognitive monitoring tools, smart home automation, and Artificial Intelligence (AI)-driven analytics. A systematic literature survey was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to identify, screen, and synthesize 236 relevant studies primarily published between 2020 and 2025 across IEEE Xplore, PubMed, Scopus and Web of Science. The inclusion criteria targeted peer-reviewed articles that proposed or evaluated iot-based solutions for ad detection, progression monitoring, or patient assistance. Key findings highlight the effectiveness of the iot in detecting behavioral and cognitive changes, enhancing safety through real-time alerts, and improving patient autonomy. The review also explores integration challenges such as data privacy, system interoperability, and clinical adoption. The study reveals critical gaps in real-world deployment, clinical validation, and ethical integration of iot-based systems for Alzheimer’s care. This study aims to serve as a definitive reference for researchers, clinicians, and developers working at the intersection of the iot and neurodegenerative healthcare.
Salvi et al. (Sat,) studied this question.